India’s emergence as a global hub for Healthcare and Life Sciences GCCs is driven by its skilled workforce, cost efficiency, and supportive regulatory landscape. Over 280,000 professionals across 100+ centers, including major players like Novartis, Pfizer, and Abbott, are utilizing cutting-edge technologies like AI, machine learning, and blockchain to innovate in R&D, clinical trials, and supply chain management. The expansion into tier-2 cities, along with government-backed policies and improved infrastructure, is expected to push the GCC market past $100 billion by 2030. Evolving from service providers to strategic partners, India’s GCCs are transforming global healthcare while significantly contributing to the nation’s economic growth.